Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Innoviva, Inc.
Bear Case (25th pct.)
92.9% vs price
Base Case (Median)
170.4% vs price
Bull Case (75th pct.)
173.7% vs price
◇ = Current price | | Bear | Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $79.24 | 286.5% | High (40%) |
| Graham Number | $39.54 | 92.9% | Medium (40%) |
| EV/EBITDA | $56.11 | 173.7% | Medium (20%) |
| EV/FCF | $55.44 | 170.5% | Medium (20%) |
| Earnings Power Value | $33.30 | 62.4% | Medium (50%) |
Based on 5 out of 7 methods, INVA appears undervalued at the current price of $20.50. The base case fair value of $55.44 implies 170.4% upside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.